PubRank

Luisa Guidi

Author PubWeight™ 27.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. Inflamm Bowel Dis 2014 2.17
2 Use of infliximab in particular clinical settings: management based on current evidence. Am J Gastroenterol 2009 2.17
3 Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study. J Crohns Colitis 2013 2.03
4 Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol 2010 1.81
5 Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission. Inflamm Bowel Dis 2013 1.12
6 Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. Eur J Immunol 2011 1.03
7 Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease. J Crohns Colitis 2013 1.00
8 Adalimumab in active ulcerative colitis: a "real-life" observational study. Dig Liver Dis 2013 0.98
9 Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity. Radiology 2011 0.91
10 Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. J Allergy Clin Immunol 2011 0.91
11 DNA damage recognition and repair capacities in human naïve and memory T cells from peripheral blood of young and elderly subjects. Mech Ageing Dev 2003 0.90
12 Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents. J Crohns Colitis 2012 0.90
13 Internet use among inflammatory bowel disease patients: an Italian multicenter survey. Eur J Gastroenterol Hepatol 2009 0.88
14 Multidetector CT enteroclysis versus barium enteroclysis with methylcellulose in patients with suspected small bowel disease. Eur Radiol 2006 0.84
15 Citation classics in periodontology: a controlled study. J Clin Periodontol 2007 0.82
16 Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases. Expert Opin Biol Ther 2015 0.82
17 Role of immune responsiveness and DNA repair capacity genes in ageing. Ageing Res Rev 2004 0.82
18 Enteroclysis CT and PEG-CT in patients with previous small-bowel surgical resection for Crohn's disease: CT findings and correlation with endoscopy. Eur Radiol 2009 0.81
19 Ileal Crohn's disease: CEUS determination of activity. Abdom Imaging 2012 0.80
20 Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience. Int J Colorectal Dis 2011 0.79
21 Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab. Drug Des Devel Ther 2013 0.78
22 CT findings and clinical activity in Crohn's disease. Clin Imaging 2009 0.78
23 Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. J Gastrointestin Liver Dis 2013 0.77
24 The DNA repair protein ku is involved in gp130-mediated signal transduction events in PBMC from young but not from elderly subjects. Exp Gerontol 2002 0.77
25 Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use. Inflamm Bowel Dis 2008 0.77
26 A case of hereditary hemorrhagic telangiectasia associated with Crohn's disease successfully treated with infliximab. Am J Gastroenterol 2010 0.76
27 AID in aging and autoimmune diseases. Autoimmunity 2013 0.76
28 The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar. Inflamm Bowel Dis 2017 0.75
29 [Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data]. G Ital Nefrol 2012 0.75
30 From initial case report to randomized clinical trial through 20 years of research in periodontal therapy. J Clin Periodontol 2008 0.75
31 Small bowel diseases. Rays 2003 0.75